Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia

Abstract Background Schizophrenia is a persistent psychotic disorder often accompanied by severe disability and premature mortality. New pharmacological treatments are urgently needed. Sodium benzoate, a common food preservative holds potential to be an effective, accessible treatment for schizophre...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Andrea Baker, Lachlan Clarke, Peter Donovan, Jacobus P. J. Ungerer, Gunter Hartel, George Bruxner, Luca Cocchi, Anne Gordon, Vikas Moudgil, Gail Robinson, Digant Roy, Ravinder Sohal, Emma Whittle, James G. Scott
Format: Artikel
Sprache:English
Veröffentlicht: BMC 2021-12-01
Schriftenreihe:Trials
Schlagworte:
Online Zugang:https://doi.org/10.1186/s13063-021-05890-6